The firm was granted U.S. approval for the treatment of metabolic dysfunction-associated steatohepatitis in adults with moderate to advanced liver fibrosis.
Recent Posts
- Watch live: Trump and Zelenskyy meet in Oval Office
- Trump administration moves to ‘prevent benefits’ for some under popular student loan forgiveness program
- China’s EV industry is spending more on factories abroad than at home for the first time
- Working longer to afford retirement is a risky plan, economists say — but some employees are counting on it
- Bitcoin sinks to $115,000 after hitting its newest record, as macro concerns spark liquidation wave